dequalinium has been researched along with paclitaxel in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vaidya, B; Vyas, SP | 1 |
Ju, RJ; Li, XT; Li, XY; Lou, JN; Lu, WL; Mu, LM; Shi, JF; Sun, MG; Zeng, F; Zhang, CX; Zhao, WY; Zhao, Y | 1 |
Weissig, V | 1 |
Cui, YN; Dian, LH; Hu, YJ; Lin, JY; Lu, WL; Su, ZB; Yan, Y; Zhang, JY | 1 |
Cheng, L; Fu, M; Ju, RJ; Li, XT; Liu, JJ; Wang, X; Xiao, Y; Xie, HJ | 1 |
Er-Bu, A; Tsering, T; Xie, HJ; Zhan-Dui, N; Zhao, J; Zhuo-Ma, D | 1 |
6 other study(ies) available for dequalinium and paclitaxel
Article | Year |
---|---|
Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Dequalinium; Drug Carriers; Drug Compounding; Drug Stability; Female; Flow Cytometry; HeLa Cells; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Mitochondria; Neoplasms; Paclitaxel; Particle Size; Solubility; Surface Properties; Tissue Distribution; Transferrin; Xenograft Model Antitumor Assays | 2012 |
Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemether; Artemisinins; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Dequalinium; Drug Delivery Systems; Glioma; Liposomes; Male; Mannose; Mice; Mice, Inbred ICR; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Vitamin E | 2014 |
DQAsomes as the prototype of mitochondria-targeted pharmaceutical nanocarriers: preparation, characterization, and use.
Topics: Animals; Cell Line; Dequalinium; Drug Carriers; Drug Compounding; Drug Delivery Systems; Humans; Liposomes; Mitochondria; Nanoparticles; Paclitaxel; Transfection | 2015 |
Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cytochromes c; Dequalinium; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Micelles; Mitochondria; Nanostructures; Paclitaxel; Polyethylene Glycols; Polyvinyls; Xenograft Model Antitumor Assays | 2018 |
Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Survival; Dequalinium; Drug Interactions; Drug Liberation; Humans; Lignans; Lung Neoplasms; Mice; Micelles; Neoplasm Metastasis; Paclitaxel; Temperature; Xenograft Model Antitumor Assays | 2018 |
Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer.
Topics: A549 Cells; Animals; Apoptosis; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Dequalinium; Down-Regulation; Drug Carriers; Drug Liberation; Extracellular Matrix; Humans; Lung Neoplasms; Mice; Micelles; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Xenograft Model Antitumor Assays | 2019 |